We thank Guarracino et al for their comments about our study, 1 in which we demonstrated that levosimendan exerts mild positive inotropic and lusitropic effects in humans with left ventricular dysfunction but does not alter the slope of the force-frequency or relaxation-frequency relationship. Guarracino et al have preliminary data suggesting that levosimendan also improves ventriculoarterial coupling in heart failure, and they raise the possibility that "arterial destiffening" may explain some of our results. However, unlike their study using intravenous drug administration, we infused levosimendan directly into the left main coronary artery, thereby avoiding changes in loading conditions that might confound the interpretation of myocardial contractility and relaxation. With this approach, we cannot comment on the effects of levosimendan on arterial elastance. However, prior studies 2 have shown that intravenous administration of levosimendan causes systemic vasodilation, in part via opening of adenosine triphosphatase-sensitive K ϩ channels.
